ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol

INTRODUCTION: Sepsis is a major cause of death among hospitalised patients. Accumulating evidence suggests that immune response during sepsis cascade lies within a spectrum of dysregulated host responses. On the one side of the spectrum there are patients whose response is characterised by fulminant...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotsaki, Antigone, Pickkers, Peter, Bauer, Michael, Calandra, Thierry, Lupse, Mihaela, Wiersinga, W Joost, Meylan, Sylvain, Bloos, Frank, van der Poll, Tom, Slim, Marleen A, van Mourik, Niels, Müller, Marcella C A, van Vught, Lonneke, Vlaar, Alexander P J, de Nooijer, Aline, Bakkerus, Lieke, Weis, Sebastian, Antonakos, Nikolaos, Netea, Mihai G, Giamarellos-Bourboulis, Evangelos J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Intensive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772655/
https://www.ncbi.nlm.nih.gov/pubmed/36600424
http://dx.doi.org/10.1136/bmjopen-2022-067251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772655/
https://www.ncbi.nlm.nih.gov/pubmed/36600424
http://dx.doi.org/10.1136/bmjopen-2022-067251

Ejemplares similares